source
- Pfizer signs $500M deal with Enodia to develop Sec61 protein degradersPfizer has entered a licensing and research collaboration with Enodia Therapeutics, valued at up to $500 million, to discover and develop inhibitors of the Sec61 protein‑translocation channel. The…
- Proposed US Census rule changes could distort health data, warns epidemiologistNancy Krieger, a professor of social epidemiology at Harvard T.H. Chan School of Public Health, wrote an opinion piece warning that proposed changes to the U.S. decennial census could have severe p…